Int. J. Environ. Res. Public Health 2009, 6(3), 1041-1054; doi:10.3390/ijerph6031041
Article

Psychoactive Medication and Traffic Safety

* email and email
Received: 1 February 2009; Accepted: 2 March 2009 / Published: 10 March 2009
(This article belongs to the Special Issue Public Health: Feature Papers)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Driving a car is important to maintain independence and participate in society. Many of those who use psychoactive medication are outpatients and are thus likely to drive a vehicle. Most common adverse effects that impair driving are reduced alertness, affected psychomotor functioning and impaired vision. This review discusses the effects on driving ability of most commonly prescribed psychoactive drugs, including hypnotics, antidepressants, antihistamines, analgesics and stimulant drugs. Within these categories of medicines significant differences concerning their impact on driving ability are evident. The International Council on Alcohol, Drugs and Traffic Safety (ICADTS) categorization can help physicians to make a choice between treatments when patients want to drive a car.
Keywords: Driving; drugs; psychoactive medication; traffic safety; ICADTS
PDF Full-text Download PDF Full-Text [444 KB, uploaded 19 June 2014 01:09 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Verster, J.C.; Mets, M.A. Psychoactive Medication and Traffic Safety. Int. J. Environ. Res. Public Health 2009, 6, 1041-1054.

AMA Style

Verster JC, Mets MA. Psychoactive Medication and Traffic Safety. International Journal of Environmental Research and Public Health. 2009; 6(3):1041-1054.

Chicago/Turabian Style

Verster, Joris C.; Mets, Monique A. 2009. "Psychoactive Medication and Traffic Safety." Int. J. Environ. Res. Public Health 6, no. 3: 1041-1054.

Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert